Patents Assigned to IngMar Medical, Ltd.
  • Patent number: 11763700
    Abstract: An airway simulation system includes a simulated airway having a hollow body defining a passageway therein with a first portion and a second portion. The second portion includes a bifurcated section having a left branch section and a right branch section and connects to the first portion at the distal end of the first portion. The simulated airway includes at least one orifice defined along the hollow body and in communication with at least one pressure transducer. One branch of the left branch section and the right branch section is configured to receive airflow from a distal end, and the other of the left branch section and the right branched section includes a cap at a distal end to prevent airflow from being received by the distal end of the capped branch. A method for simulating a human airway is also disclosed.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: September 19, 2023
    Assignee: IngMar Medical, Ltd.
    Inventors: Stefan Frembgen, James J. Fialho, Joel Neatrour
  • Patent number: 11521518
    Abstract: An airway simulation system includes a simulated airway having a hollow body defining a passageway therein with a first portion and a second portion. The second portion includes a bifurcated section having a left branch section and a right branch section and connects to the first portion at the distal end of the first portion. The simulated airway includes at least one orifice defined along the hollow body and in communication with at least one pressure transducer. One branch of the left branch section and the right branch section is configured to receive airflow from a distal end, and the other of the left branch section and the right branched section includes a cap at a distal end to prevent airflow from being received by the distal end of the capped branch. A method for simulating a human airway is also disclosed.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: December 6, 2022
    Assignee: IngMar Medical, Ltd.
    Inventors: Stefan Frembgen, James J. Fialho, Joel Neatrour
  • Patent number: 11037467
    Abstract: A suction simulation device includes a suction catheter and a suction unit in fluid communication with the suction catheter. The suction unit includes a reservoir for holding fluid and the suction unit is configured to provide vacuum capability to the suction catheter. The suction simulation device also includes a pump in fluid communication with the suction unit, the pump configured to flow the fluid from the reservoir. The suction simulation device is adapted for use with a manikin comprising an airway. Also disclosed is a suction simulation system and a method of simulating a scenario requiring mechanical ventilation.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: June 15, 2021
    Assignee: IngMar Medical, Ltd.
    Inventors: Stefan Frembgen, Amanda Dexter
  • Patent number: 10052224
    Abstract: A snore module device that simulates patients' breathing patterns by producing pressure and flow oscillations similar to those encountered in actual patients for use with a breathing simulator generating breathing waveforms and controller/interface includes a moving platen driven by a linear motor or voice coil providing changes in the aperture of a passage of air through an air gap by moving the platen relative to the ceiling of a chamber.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: August 21, 2018
    Assignee: IngMar Medical, Ltd.
    Inventor: Stefan Frembgen
  • Patent number: 9463292
    Abstract: A respiratory metabolic simulator includes a cell that produces CO2 and depletes O2, e.g., a direct methanol fuel cell having an external electrical circuit. An electric load is applied to the external electrical circuit of the direct methanol fuel cell to vary the electrical load applied to the external electrical circuit of the direct methanol fuel cell to produce carbon dioxide. The carbon dioxide generated by the direct methanol fuel cell is supplied to respiration gases produced by the respiratory metabolic simulator. The direct methanol fuel cell is also used to remove oxygen from the respiration gases prior to mixing the respiration gases and the carbon dioxide.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: October 11, 2016
    Assignee: IngMar Medical, Ltd.
    Inventor: Stefan Frembgen
  • Publication number: 20120060933
    Abstract: A respiratory metabolic simulator includes a cell that produces CO2 and depletes O2, e.g., a direct methanol fuel cell having an external electrical circuit. An electric load is applied to the external electrical circuit of the direct methanol fuel cell to vary the electrical load applied to the external electrical circuit of the direct methanol fuel cell to produce carbon dioxide. The carbon dioxide generated by the direct methanol fuel cell is supplied to respiration gases produced by the respiratory metabolic simulator. The direct methanol fuel cell is also used to remove oxygen from the respiration gases prior to mixing the respiration gases and the carbon dioxide.
    Type: Application
    Filed: September 14, 2011
    Publication date: March 15, 2012
    Applicant: INGMAR MEDICAL, LTD.
    Inventor: Stefan Frembgen
  • Patent number: 7959443
    Abstract: A system and method of delivering CO2 in a respiration closed-loop control system to a respiratory simulator includes (a) providing a CO2 supply to a respiratory simulator having a piston/cylinder arrangement; (b) providing flow control hardware between the CO2 supply and the piston/cylinder arrangement; (c) generating a first control signal representative of a predefined amount of CO2; and (d) providing the predefined amount of CO2 into the piston/cylinder arrangement. Thereafter, either (i) an end-tidal carbon dioxide partial pressure (EtCO2) value is determined based on an amount of CO2 emptied from the piston/cylinder arrangement during an exhalation phase of the respiratory simulator or (ii) an EtCO2 value is calculated via an equation. A second control signal is generated that is representative of a tidal volume and a breathing frequency representative of a physiological response to the EtCO2 value to effect corresponding movement of the piston in a next inhalation and exhalation phase.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: June 14, 2011
    Assignee: IngMar Medical, Ltd.
    Inventors: Stefan Frembgen, Maik Gremme